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Abstract: Bacteriophages are appropriate gene carriers that might be targeted toward target cells using different strategies. Here we
prepared a transferrin-targeted M13-based gene nanocarrier (Tf-targeted M13-GFP) and examined its gene delivery and expression
efficacy in the AGS cell line. M13 phagemid particles bearing a GFP expression cassette (M13-GFP) were obtained from a recombinant
lambda phage through an in vivo excision procedure. Chemical coupling of human holotransferrin molecules (Tf) to the surface of
these phagemid particles resulted in Tf-targeted M13-GFP formation, which was then characterized by Phage-ELISA and Cell-ELISA
experiments. Immunocytochemistry (ICC) and fluorescence-activated cell sorting (FACS) analysis were used for internalization assay
and examination of gene delivery/expression efficacies in the human AGS cell line. The ELISA experiments revealed high-density
attachment of Tf molecules to the surface of M13-GFP particles and ICC confirmed highly efficient internalization of the Tf-targeted
M13-GFP particles into the AGS cells. Moreover, FACS analysis showed significant increase of GFP-positive cell counts in the samples
treated with Tf-targeted M13-GFP (8.09%) in comparison with the samples treated with wild M13-GFP (1.2%). We conclude that this
strategy might improve phage-mediated gene delivery and expression in eukaryote cells.
Key words: Chemical coupling, phage-mediated gene transfer, gene delivery, transferrin-targeted delivery

1. Introduction
One of the most important issues of gene therapy is
to achieve efficient, safe, and targeted gene carriers.
Bacteriophages might be suitable candidates for this
purpose due to characteristics including protection
of transgenes by coat proteins, having no tropism for
eukaryote cells, ease of targeting by phage display and/or
chemical coupling approaches, low-cost and large-scale
production, physical stability, ease of genetic manipulation,
safety, and relative immunotolerance (Poul and Marks,
1999). These characteristics have made bacteriophages
attractive gene carriers. These particles can especially be
adopted for cancer therapy, either with suicide gene or
anticancer drug delivery to the cancerous tissues/cells
(Urbanelli et al., 2001; Li et al., 2010; Stephanopoulos et
al., 2010; Huang et al., 2011; Shoae-Hassani et al., 2013a,
2013b). Two main approaches that can be exploited
for targeted delivery of bacteriophages into eukaryote
cells are phage display and chemical coupling strategies.
Chemical coupling might be achieved by crosslinking an
active group from a targeting molecule to another active
group (such as –COOH and –NH3) present on the phage
* Correspondence: khalaj@tabrizu.ac.ir

coat proteins. Thus, the targeting of gene carriers such as
bacteriophages can be achieved directly through simple
and various chemical reactions without need for complex
genetic manipulations (Khalaj-Kondori et al., 2011).
Transferrin is one of the appropriate targeting molecules
for drug and gene delivery to cancer cells and tissues
because cancer cells overexpress transferrin receptors on
their surfaces for acquiring the iron needed for their rapid
growth and metabolism (Qian et al., 2002). Transferrin has
been successfully applied for targeted delivery of various
nanodrugs and nanoparticles. For example, targeting of
liposome nanoparticles with transferrin resulted in specific
entering of liposomes into the cancer cells in vitro and
solid tumor tissues in vivo (Ishida et al., 2001). Moreover,
an artemisinin-transferrin conjugate was used to inhibit
the growth of prostate cancer cells (Nakase et al., 2009). In
another work, transferrin molecules were coupled to the
surface of bacteriophage HK97 particles that were already
labeled with fluorescein molecules. This strategy showed
efficient uptake of HK97 particles by different cell lines,
which resulted in high-density fluorescent signals in the
cells (Huang et al., 2011).
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This study was aimed to formulate a transferrintargeted M13-based gene nanocarrier using a chemical
coupling strategy and to evaluate its potential for transgene
delivery and expression in eukaryote cells. Human
holotransferrin molecules were coupled on the surface of
recombinant bacteriophage M13 particles bearing a GFP
transgene (M13-GFP), which resulted in formulation
of a transferrin-targeted M13-GFP gene nanocarrier.
Finally, the carrier was characterized and evaluated using
the human gastric adenocarcinoma AGS cell line (ATCC
CRL-1739).
2. Materials and methods
2.1. Preparation of M13-GFP phage particles
We have already reported the construction of a recombinant
lambda phage bearing a GFP encoding sequence (λ-GFP)
using the lambda ZAP-CMV XR (Stratagene, USA) vector
(Khalaj-Kondori et al., 2010). The lambda ZAP-CMV
XR vector has been designed in such a way that after
cloning it permits any inserted sequence to be obtained as
a pCMV-Script phagemid particle by an in vivo excision
mechanism. Therefore, we used the recombinant λ-GFP
phage for preparation of M13-GFP phage particles. E.
coli XL1-Blue MRF’ cells (Stratagene) grown in LB broth
supplemented with 20% (w/v) maltose and 10 mM MgSO4
were infected with the λ-GFP phage. The culture was then
titered and the plates were incubated for 12 h at 37 °C. The
appeared plaques were confirmed by plaque-PCR using
GFP-specific primers. One of the positive plaques was
amplified and used for obtaining the pCMV-Script-GFP
phagemid construct by in vivo excision protocol. For in
vivo excision, 50 mL of LB broth supplemented with 20%
(w/v) maltose and 10 mM MgSO4 was inoculated with E.
coli Xl1-Blue MRF’ and incubated overnight at 37 °C with
vigorous shaking. The culture was centrifuged at 1000 × g
for 10 min and the precipitate was dissolved in 25 mL of
of 10 mM MgSO4. Its OD600 was measured and adjusted to
an OD600 of 1.0 (8 × 108 cells/mL) by 10 mM MgSO4. In a
Falcon 2059 polypropylene tube, 200 µL of the prepared
E. coli Xl1-Blue MRF’ solution was mixed with 250 µL of
λ-GFP phage solution (more than 105 phage particles) and
1 µL of ExAssist helper phage (Stratagene) containing more
than 106 particles and incubated for 15 min at 37 °C with
no shaking. Three milliliters of LB broth with supplements
was then added to the Falcon tube, which was incubated
for 3 h at 37 °C with shaking. The tube was heated at 70
°C for 20 min to lyse the lambda phage particles/cells and
spun at 1000 × g for 15 min to pellet the cell debris. The
supernatant that contained M13-GFP phage particles was
transferred to a fresh Falcon tube and stored at 4 °C for
future use.
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2.2. Confirmation, amplification, and preparation of
M13-GFP phage particles for chemical coupling reaction
E. coli XLOLR (500 µL; Stratagene) grown in LB broth was
infected with 10 µL of the M13-GFP phage solution and
incubated for 1 h at 37 °C, and then 10 µL of it was plated
on LB agar with 50 µg/mL kanamycin (Sigma-Aldrich,
Germany) and the plate was incubated for 16 h at 37 °C.
The appeared colonies were analyzed by colony-PCR
using GFP-specific primers. One of the positive colonies
was inoculated into 5 mL of 2X YT broth containing 50
µg/mL kanamycin and R408 helper phage (Stratagene)
(multiplicity of infection (MOI): ~10) and incubated for 8
h. The culture was then transferred into 200 mL of fresh 2X
YT broth containing 50 µg/mL kanamycin and incubated
for 18 h at 37 °C. The culture was heated to 70 °C for 20
min and cell debris was collected by centrifugation at 5000
rpm for 10 min. The supernatant was transferred into fresh
Falcon tubes and polyethylene glycol 8000 and NaCl were
added in final concentrations of 10% and 1 M, respectively.
The phage M13-GFP particles were then precipitated by
incubation for 60 min on ice and the precipitant was
collected by centrifugation at 17,000 × g and 4 °C for 20
min. The pellet was resuspended in SM buffer and titered.
The titer of M13-GFP particles was calculated by the
following formula (Mount et al., 2004):
virions/mL = A269 × 6 × 1016/number of nucleotides in
the genome,
where A269 is the absorbance of M13-GFP solution at 269
nm.
M13-GFP phage particles (5 mL of 1 × 1011 cfu/mL)
in SM buffer were purified and concentrated with 150K
MWCO concentrator (Thermo Scientific Pierce, USA)
and its buffer was exchanged with PBS (0.1 M sodium
phosphate, pH 7.2). The final volume was adjusted to 5
mL and its absorbance at 269 nm was measured, and the
number of phage particles was determined by the above
formula.
2.3. Oxidation of human holotransferrin
Oxidation of transferrin creates aldehyde reactive groups
on its N-glycoside chains (Khalaj-Kondori et al., 2011),
which in turn might be used for cross-linking to the other
reactive groups. For oxidation, human holotransferrin
(Sigma-Aldrich) was dissolved to 1 mg/mL in 0.1 M
sodium acetate buffer, pH 5.5. Sodium metaperiodate
(Sigma-Aldrich) was added to a final concentration of 10
mM and protected from light. The reaction mixture was
incubated for 30 min at room temperature. The reaction
solution was dialyzed (Cellu Sep, T-Series Membranes) in
PBS (0.1 mM sodium phosphate, pH 7.2) for purification
and buffer exchange. The iron content of holotransferrin
was measured through comparison of its A470/A280 ratios
before and after oxidation reaction.
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2.4. Chemical coupling reaction
For coupling reaction we mixed 2 mL of oxidized
holotransferrin (0.125 mg/mL in PBS buffer; 0.1 M sodium
phosphate, 0.15 M NaCl, pH 7.2) with 5 mL of M13-GFP
phages in PBS (0.1 M sodium phosphate, pH 7.2; ~5 × 1011
phage particles). Then 70 µL of 5 M NaCNBH3 (SigmaAldrich; final concentration 50 mM) was added to the
solution and incubated overnight at 4 °C. The reaction was
then quenched by adding 200 µL of Tris-HCl (pH 7.4). The
coupling reaction product was purified and concentrated
with 150K MWCO concentrator. This solution, which now
contained holotransferrin-coupled M13-GFP particles
(Tf-targeted M13-GFP gene nanocarrier), was diluted in
5 mL of PBS buffer (pH 7.4) and its absorbances at 260,
269, and 280 nm were measured. The concentration of
Tf-targeted M13-GFP particles was calculated by the
abovementioned formula.
2.5. Phage-ELISA
Phage-ELISA was done according to our previous report
(Khalaj-Kondori et al., 2011). First, 100 µL of PBS
containing 100 µg/mL rabbit M13 phage coat protein
antibody (Thermo Scientific) was coated into the wells of
an ELISA plate (Nunc, Denmark). The coating solution was
discarded and the wells were washed with washing buffer
(0.05% Tween 20 in PBS). The coated wells and the purified
wild M13-GFP phage solution as well as the Tf-targeted
M13-GFP particles were blocked with blocking buffer
(3% milk in PBS) at room temperature for 30 min. After
discarding the blocking solution, wells were washed and
incubated either with about 109 wild M13-GFP particles or
blocked Tf-targeted M13-GFP at room temperature for 60
min. After washing, the wells were treated with antihuman
transferrin IgG-HRP conjugate (Alpha Diagnostic
International Inc., USA) (1:1000 dilutions in blocking
buffer) at room temperature for 60 min. The solution
was then discarded. The wells were washed three times,
and then 100 µL of TMB (Thermo Scientific Pierce) was
added to each well and the reaction was stopped by H2SO4.
Absorbance of the developed solution was measured by
ELISA reader (Bio-Rad Microplate Reader) at 450 nm.
2.6. Quantification of coupled transferrin molecules
Four serial dilutions of holotransferrin in PBS with known
concentration were coated into the wells of a 96-well plate,
each with two replicates. Aliquots (100 µL) of a purified
Tf-targeted M13 GFP solution in PBS, each with about 109
particles, were coated into the wells in triplicate format. The
plate was incubated overnight at 4 °C. The solutions were
collected from wells and their absorbances were measured
to subtract transferrin molecules or Tf-targeted M13-GFP
particles that had not attached to the wells. The wells were
washed (0.05% Tween 20 in PBS) and blocked (3% milk in
PBS) at room temperature for 60 min. The wells were then
poured off and rinsed, and 100 µL of antihuman transferrin

IgG-HRP conjugate (Alpha Diagnostic International
Inc.) (1:1000 dilutions in blocking buffer) was added to
each well and incubated at room temperature for 60 min.
After discarding the solution, wells were washed three
times and 100 µL of TMB was added to each well. The
developing reaction was stopped by H2SO4 and A450 was
read by an ELISA reader (Bio-Rad Microplate Reader).
The absorbances of the holotransferrin-coated wells were
used to obtain a standard curve, which used for estimation
of the approximate milligrams of transferrin present in
the wells coated with the Tf-targeted M13-GFP particles.
The number of transferrin molecules coupled per phage
particle was estimated considering the molecular weight
of transferrin.
2.7. Cell-ELISA
About 20,000 AGS cells/well were seeded in a 96-well plate
and incubated at 37 °C until 90% confluency. Cells were
washed with PBS and fixed by paraformaldehyde 4% (v/v)
in RPMI at 4 °C for 10 min. Wells were rinsed with cold PBS
and blocked with 3% milk in PBS at room temperature for
60 min. After discarding the blocking solution, wells were
washed with washing buffer and incubated with 100 µL of
holotransferrin (1:1000 dilutions of 1 mg/mL) in blocking
buffer at room temperature for 60 min. The solution was
poured off and wells were rinsed with washing buffer and
incubated with 100 µL of antihuman transferrin IgG-HRP
conjugate (Alpha Diagnostic International Inc.) (1:1000
dilutions in blocking buffer) at room temperature for 60
min. The solution was discarded and wells were washed
with washing buffer, and then 100 µL of TMB was added
to each well. After 30 min the reaction was stopped by
10 µL of 0.5 M sulfuric acid. The absorbances at 450 nm
were then read by an ELISA reader (Bio-Rad Microplate
Reader).
2.8. Internalization assay
Internalization assay was done according to our previous
report (Khalaj-Kondori et al., 2011). About 105 AGS cells
per well were seeded on coverslips in 6-well plates 24 h
before treatments. The cells were treated with either
Tf-targeted M13-GFP or wild M13-GFP at MOI of
105 and incubated for 3 h at 37 °C. Cells with no phage
treatment were used as a negative control. The medium
was removed and the coverslips were washed with PBS.
Phage particles bound to the cell membrane were eluted
by glycine buffer (50 mM glycine, pH 2.8, 500 mM NaCl).
The cells were washed with PBS and fixed with PBS and
3.7% paraformaldehyde for 5 min at room temperature.
Cells were then permeabilized with 0.2% Triton X-100 in
PBS, washed, and blocked with 3% BSA in PBS. They were
incubated with rabbit M13 phage coat protein antibody
(Thermo Scientific) diluted 1/100 in PBS and 1% BSA at
room temperature for 60 min. After washing (0.01% Tween
20, 0.1% BSA in PBS), the coverslips were treated with the
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secondary antibody Alexa-555 (Molecular Probes, the
Netherlands; diluted 1/300 in PBS and 1% BSA) at room
temperature for 45 min. A drop of DAPI stain was placed
on each glass slide and after washing of the coverslips they
were inverted onto the DAPI spots. The sides of coverslips
were sealed with nail polish and analyzed with a Zeiss
fluorescence microscope.
2.9. Transfection of AGS cells by Tf-targeted M13-GFP
AGS cells (1 × 105 cells/well) were seeded into 6-well plates
24 h prior to transfection. Cells were treated with either
109 Tf-targeted M13-GFP or 109 wild-type M13-GFP or,
for competition assay, 109 Tf-targeted M13-GFP particles
plus 1 µg of holotransferrin. Wells with no phages were
used as a negative control. After incubation for 4 h at 37
°C, the media were changed with fresh complete medium
and incubated for 48 h. Cells were then collected and fixed
with 5% paraformaldehyde in PBS at room temperature
for 20 min. The cells were washed with PBS, resuspended
in 500 µL of PBS containing 0.01% sodium azide, and
analyzed by fluorescence-activated cell sorting (FACS;
Becton Dickinson Biosciences, USA). The percentage of
GFP-positive cells per total counted cells was reported
as transfection efficiency. Transfections were done in
duplicate and performed three times.
3. Results
3.1. Preparation of M13-GFP phage particles
The recombinant lambda phage bearing the GFP cassette
(λ-GFP) (Khalaj-Kondori et al., 2010) was amplified and
confirmed by plaque-PCR. One of the confirmed λ-GFP
plaques was used for in vivo excision of the pCMV-ScriptGFP phagemid. The in vivo excision procedure resulted
in packaging of the pCMV-Script-GFP construct as M13GFP phage particles, which were then used for infection
of E. coli XLOLR cells. XLOLR colonies containing the
pCMV-Script-GFP construct were confirmed by colonyPCR (Figure 1).
3.2. Evaluation of transferrin receptor expression on the
AGS cell line
Transferrin receptor (Tfr) expression on the surface of
AGS cells was evaluated by Cell-ELISA. Holotransferrin
molecules that bonded to the Tfr(s) on the cell membrane
of fixed AGS cells in Cell-ELISA experiments were detected
by antitransferrin HRP conjugate. The results showed that
AGS cells expressed Tfr on their surface and it was suitable
for transferrin-targeted delivery (Figure 2).
3.3. Preparation and characterization of Tf-targeted
M13-GFP gene nanocarrier
3.3.1. Chemical coupling
For preparation of the Tf-targeted M13-GFP gene
nanocarrier, human holotransferrin molecules were
coupled chemically to the surface of M13-GFP phage
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Figure 1. Electrophoresis of the colony-PCR products; P.C:
positive control, N.C: negative control.
1.2
1
0.8
A 0.6
0.4
0.2
0
Cell

No cell

Figure 2. Cell-ELISA showing expression of transferrin receptors
on the AGS cells. AGS cells were seeded in ELISA plate wells in
triplicate format and treated with pure human holotransferrin.
Presence of Tfr(s) on the AGS cells was detected by adding HRPconjugated antihuman transferrin. Wells with no cells were used
as a negative control. A: absorbance.

particles. The overall reaction is depicted in Figure 3.
To do this, holotransferrin was treated with sodium
metaperiodate for oxidation of its sugar chains. It was
reported that sodium metaperiodate causes oxidative
damage to tyrosine residues and hence the tyrosine
residue at the iron binding site of transferrin might be
partially oxidized (Lai et al., 2005; Khalaj-Kondori et al.,
2011). Oxidation of tyrosine at the iron binding site results
in release of iron ions, which in turn may reduce the
binding affinity of transferrin to its receptors on the cell
surface (Lai et al., 2005). To reveal the effect of oxidation
on the iron content of holotransferrin, the absorbances
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3

2

Tf-targeted M13-GFP
Figure 3. Schematic representation of chemical coupling reaction; oxidation of transferrin results in production of aldehyde reactive
groups on the carbohydrate chains of transferrin molecules. Aldehyde groups can react with –NH2 groups present at tyrosine
residues of coat proteins. This reaction leads to a Schiff base intermediate that temporally links the phage particles with transferrin
molecules. Reduction of the intermediate complex with NaCNBH3 results in formulation of the Tf-targeted M13-GFP nanocarrier
in which transferrin molecules are covalently attached to the phage surface.

of the holotransferrin solution before and after oxidation
reaction were measured at 470 and 280 nm. The A470/A280
ratios for holotransferrin and oxidized transferrin were
0.058 ± 0.004 and 0.037 ± 0.007, respectively. These results
showed that the iron content of the oxidized transferrin
in comparison to nonoxidized holotransferrin was
approximately 64%.
3.3.2. Detection of coupled transferrin molecules
Phage-ELISA was used to reveal the coupled transferrin
molecules to the surface of phage particles. Phage particles
with or without coupled transferrin molecules were
trapped by anti-M13 antibody, which had been coated in
the wells. The coupled transferrin molecules to the phage
surface were then detected by HRP-conjugated antihuman
transferrin. Phage-ELISA experiments confirmed the
successful attachment of transferrin to the surface of phage
particles and hence obtaining of the Tf-targeted M13-GFP
particles (Figure 4).
3.3.3. Quantitation of transferrin molecules coupled per
phage
To reveal the average number of transferrin molecules
coupled per phage particle, ELISA was used. Either serial
dilutions of holotransferrin or purified Tf-targeted M13GFP particles were coated in the wells. The absorbances
obtained from holotransferrin-coated wells were utilized
to make a standard curve (Figure 5), the formula of which
was then used for obtaining the nanograms of transferrin
present in the wells coated with Tf-targeted M13-GFP

0.9
0.8
0.7
0.6
A

0.5
0.4
0.3
0.2
0.1
0
N

M13

Tf-M13

Figure 4. Phage-ELISA; ELISA plate wells were coated with
rabbit anti-M13. After blocking and washing, the wells were
treated with 109 M13-GFP (M13), Tf-targeted M13-GFP (TfM13) particles, or no phages (N) in triplicate format. Attachment
of transferrin molecules to the phage particles was detected by
adding HRP-conjugated antihuman transferrin. A: absorbance.

particles. The Table shows a summary of the calculations.
Knowing the number of Tf-targeted M13-GFP particles
coated in each well and the molecular weight of transferrin
(78 kDa), we calculated the number of transferrin
molecules coupled per phage particle. The results showed
that, on average, 397 transferrin molecules had been
coupled to each phage particle.
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y = 0.0150x + 0.143
R2 =0.985
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Figure 5. Standard curve used for estimating the number of
transferrin molecules coupled per phage. A: absorbance, Tf:
transferrin.

3.3.4. Evaluation of binding capacity and functionality
To find out whether transferrin molecules coupled to the
surface of phage particles retained their functionality/
ability for binding to the transferrin receptors on the cell
surface, Cell-ELISA was performed. AGS cells were seeded,
fixed, and blocked in a 96-well plate. Cells were then treated
with Tf-targeted M13-GFP, holotransferrin, M13-GFP
phages, or nothing. The trapped transferrin molecules or
Tf-targeted M13-GFP on the surface of cells was detected
with HRP-conjugated antihuman transferrin. The results
showed that the absorbance value for wells treated with Tftargeted M13-GFP was lower than that of the wells treated
with holotransferrin, while it was significantly higher than
that of the wells treated with wild-type M13-GFP (data not
shown). These results imply that the transferrin molecules
that coupled to the surface of M13-GFP phages were active
and could interact with cell surface transferrin receptors.

3.4. Internalization of Tf-targeted M13-GFP into AGS
cells
Internalization of the Tf-targeted M13-GFP particles with
AGS cells was studied with immunocytochemical (ICC)
staining. Figure 6 shows that the cells treated with Tftargeted GFP-M13 and permeabilized with Triton X-100
efficiently internalized the gene nanocarrier and produced
more and brighter fluorescence signals due to interactions
between Tf-targeted M13-GFP/anti-M13/Alexa-555
labeled secondary antibodies. Those cells permeabilized
and treated with wild M13-GFP phages showed faint
fluorescence signals. These observations reveal that
Tf-targeted M13-GFP particles internalized with AGS
cells via specific interactions between the transferrin
molecules attached to the M13-GFP phage particles and
the transferrin receptors on the AGS cells. Moreover, no
signals were observed in the nonpermeabilized cells,
which in turn confirmed that the observed signals were
due to immunoreaction with the internalized particles
rather than particles adhering to the cells surface.
3.5. Transfection of AGS cells with Tf-targeted M13-GFP
To reveal Tf-targeted M13-GFP-mediated transgene
delivery and expression in AGS cells, FACS analysis was
used. AGS cells were seeded in 6-well plates and treated
with Tf-targeted M13-GFP or M13-GFP particles at MOI of
104. After 48 h, cells were collected and analyzed by FACS.
The results showed 8.09% GFP-positive cells for the wells
treated with Tf-targeted M13-GFP, whereas it was 1.2% for
the wells treated with naive M13-GFP particles (Figures
7A and 7B). Moreover, addition of 1 µg of holotransferrin
together with 109 Tf-targeted M13-GFP particles could
efficiently prevent transfection of the AGS cells and
resulted in 1.55% GFP-positive cells (Figure 7C). FACS
allows not only the counting of the number of positive
transfected cells but also measurement of the intensity

Table. Calculating the number of transferrin molecules coupled per phage.
Equation

y = 0.01505x + 0.143

y: mean of absorbances

0.711

x: ~nanograms of transferrin per well

37.74 ng

1 ng Tf

7.8 × 109 molecules

Number of Tf molecules in the well

294.4 × 109 molecules

Number of Tf-targeted M13-GFP particles used for coating per well

1 × 109

Number of uncoated Tf-targeted M13-GFP particles per well

2.6 × 108

Number of Tf-targeted M13-GFP particles coated per well

7.4 × 108

Number of Tf molecules coupled per phage (294.4 × 109 / 7.4 × 108 )

397 molecules
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Figure 6. Immunocytochemical staining for internalization assay; AGS cells were seeded on coverslips
in 6-well plates and incubated for 24 h. Either Tf-targeted M13-GFP or wild M13-GFP particles were
added to the wells at a MOI of 105 and incubated for 3 h at 37 °C. Cells with no phage treatment were used
as a negative control. The wells were then washed with PBS and cell membrane-bound phage particles
were eluted by glycine buffer. The cells were fixed and permeabilized (left) or not permeabilized (right)
with Triton X-100 and treated with the rabbit anti-M13 antibody. Coverslips were incubated with the
secondary antibody Alexa-555, washed, and inverted onto a drop of DAPI stain on glass slides. The
coverslips were analyzed using a Zeiss fluorescence microscope.

1000

806.25

MFI

800
600
400
200

108.39

37.75

22.11

C

D

0
A

B

Figure 7. Left: FACS analysis of AGS cells treated with 109 Tf-targeted M13-GFP (A), 109 wild M13-GFP (B), 109 Tf-targeted
M13-GFP particles plus 1 µg holotransferrin (C), or no phages (D). Transfections were done with a MOI of 104. Right: Mean
fluorescence intensity (MFI) of the GFP-positive cells for the same treatments.
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of fluorescent signals of individual GFP-positive cells.
Results showed that mean fluorescence intensity (MFI) of
the cells transfected with Tf-targeted M13-GFP was about
eight-fold more than the MFI of the cells transfected with
naive M13-GFP particles (Figure 7). These results revealed
that coupling of transferrin molecules to the surface of
M13-GFP particles might result in improvements not only
in the number of transfected cells but in the transgene
expression as well.
4. Discussion
Targeting of cancerous, infected, or malfunctioning cells
with therapeutic genes is very important for treatment
of patients. However, there are some obstacles including
safety, efficiency, and specificity of gene carriers.
Animal viral vectors are the most efficient gene delivery
systems, but they suffer from risk of intrinsic toxicity as
well as the high cost for their production (Chung et al.,
2008). One alternative that has attracted researchers is
bacteriophages. These bacterial viruses can be targeted
toward eukaryote cells/tissues by displaying cell/tissue
type-specific targeting molecules such as small peptides,
receptor-specific ligand molecules, and antibodies on their
surfaces (Khalaj-Kondori et al., 2011; Shoae-Hassani et
al., 2013b). Targeting molecules can be displayed on the
surface of phage particles either via common phage display
technology (Poul and Marks, 1999; Urbanelli et al., 2001;
Mount et al., 2004) or with chemical coupling strategies (Li
et al., 2010; Huang et al., 2011; Khalaj-Kondori et al., 2011).
Chemical coupling has been applied as a straightforward
strategy for linking targeting molecules and/or drugs
with nanoparticles/nanobioparticles. In particular, this
strategy has achieved some insights in imaging (Singh et
al., 2006; Li et al., 2010; Huang et al., 2011) and drug/gene
delivery (Stephanopoulos et al., 2010; Khalaj-Kondori et
al., 2011; Shoae-Hassani et al., 2013a, 2013b; Bakhshinejad
and Sadeghizadeh, 2014; Bakhshinejad et al., 2014) using
targeted bacteriophage particles.
In the present study we used the chemical coupling
strategy for formulation of a transferrin-targeted
bacteriophage M13-based (Tf-targeted M13-GFP) gene
nanocarrier. The M13-GFP phage particles were obtained
with an in vivo excision procedure from a recombinant
λ-GFP phage. Subsequently, human holotransferrin
molecules were coupled to the surface of the M13-GFP
phage particles, which resulted in the formulation of the
Tf-targeted M13-GFP gene nanocarrier. For coupling,
the carbohydrate chains of human holotransferrin were
oxidized. Oxidation might damage tyrosine residues
present in the iron binding site of holotransferrin, which
in turn might lead to the release of iron molecules and
reduction of its interaction with cell surface transferrin
receptors (Lai et al., 2005, 2009). Monitoring of the A470/

568

A280 ratios of the solution before and after oxidation showed
36% reduction in the iron content of holotransferrin, which
was in the range of reports by others (Mount et al., 2004; Lai
et al., 2005; Khalaj-Kondori et al., 2011). Characterization
of the Tf-targeted M13-GFP gene nanocarrier revealed
that an average of 397 transferrin molecules were coupled
per phage particle. This achievement is valuable, because it
was reported that the copy number of displayed/coupled
targeting molecules on the phage/nanoparticle surface
dictates the efficiency of internalization of them by cells
(Ivanenkov et al., 1999a; Mount et al., 2004; Li et al., 2005).
Moreover, transferrin is a large and complex glycoprotein
and displaying of it in high copy numbers on the phage
surface with the common phage display approach seems to
be impossible. Assembling of phage particles in the case of
using coat proteins fused with bigger and complex proteins
would be insufficient (Ivanenkov et al., 1999b; Gupta et al.,
2003; Hodyra and Dąbrowska, 2015).
Internalization of the Tf-targeted M13-GFP particles
with AGS cells was studied by ICC. The ICC experiments
showed that the targeted particles had been internalized
with very high efficiency by the cells (Figure 6). This
achievement might be due to the high copy number of
transferrin molecules attached to the phage particles.
In contrast to the very highly efficient internalization,
the count of GFP-positive cells obtained with FACS was
about 8.09%. This implies that the internalization is not
sufficient by itself and there are some barriers on the way
to the nucleus that need to be removed. One of the possible
determinants might be the conformation/structure of the
phage genome (Abedheydari et al., 2014). There are some
strategies for getting rid of the barriers. For example, Volcy
and Dewhurst (2009) studied the effect of inhibitors of
proteasome as well as lysosomal proteases. They showed
that these inhibitors strongly enhanced the phagemediated transgene expression, suggesting that these
pathways contribute to the destruction of intracellular
phage particles. One alternative might be displaying the
nucleus localization signal (NLS) peptide on the phage
surface. In this way, Eguchi et al. (2005) improved the
nuclear transport of lambda phage particles displaying
peptides containing the minimum NLS of SV40 T antigen
on their surface. Moreover, the targeting molecules
displayed on the phage surface dictate their internalization
and intracellular trafficking route. Kim et al. showed that
3D8 VL-M13 phages (M13 displaying a cell-penetrating
light chain variable domain 3D8 VL transbody) routed to
the cytosol and remained stable for more than 18 h without
further trafficking to other subcellular compartments,
whereas TAT-M13 phages (M13 displaying TAT peptide)
routed to several subcellular compartments before being
degraded in lysosomes even after 2 h of internalization
(Kim et al., 2012). These studies emphasize that it would
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be possible to increase the phage-mediated gene transfer
either by recruiting a proper targeting molecule or with
combined targeting molecules/strategies.
In conclusion, the results showed that the Tf-targeted
M13-GFP gene nanocarrier was able to interact efficiently
with the transferrin receptors on AGS cells, be internalized
with them, and deliver encapsulated DNA into the cells,
leading to enhancement of the transgene expression in
AGS cells. Moreover, our results further confirmed that
the chemical coupling approach might be considered as

a straightforward strategy for attaching more targeting
ligands to the surface of phage particles with the aim
of improving phage-mediated transgene delivery to
eukaryote cells.
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